Integra LifeSciences
Integra LifeSciences To Host Investor Day On May 4, 2023
03 mai 2023 07h00 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30...
Integra LifeSciences
Integra LifeSciences Reports First Quarter 2023 Financial Results
26 avr. 2023 06h00 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences
Integra LifeSciences to Host First Quarter 2023 Financial Results Conference Call on April 26, 2023
03 avr. 2023 08h00 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2023 financial...
Integra LifeSciences
Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
22 févr. 2023 06h00 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences
Integra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023
09 févr. 2023 07h30 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial...
Integra LifeSciences
Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
10 janv. 2023 16h30 HE | Integra LifeSciences Holdings Corporation
Fourth Quarter 2022  Fourth quarter 2022 revenue is expected to be in a range of $397 million to $398 million, representing a decrease of approximately 2% on a reported basis and an increase of...
Integra LifeSciences
Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference
21 déc. 2022 17h00 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president...
Integra LifeSciences
Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates
06 déc. 2022 17h00 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed...
Integra LifeSciences
Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase
01 déc. 2022 08h00 HE | Integra LifeSciences Holdings Corporation
Acquisition will add distinct new product solution for plastic and reconstructive surgery to address clinical needs and improve patient outcomes Deploys capital to support strong profitable growth...
Integra LifeSciences
Integra LifeSciences Reports Third Quarter 2022 Financial Results
26 oct. 2022 06h01 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...